Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Silence Therapeutics (SLN) over the last 3 years, with Q3 2025 value amounting to $399000.0.
- Silence Therapeutics' Other Non-Current Assets fell 8567.68% to $399000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $399000.0, marking a year-over-year decrease of 8567.68%. This contributed to the annual value of $3.6 million for FY2024, which is 153.59% down from last year.
- As of Q3 2025, Silence Therapeutics' Other Non-Current Assets stood at $399000.0, which was down 8567.68% from $3.9 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Other Non-Current Assets ranged from a high of $3.9 million in Q2 2025 and a low of $399000.0 during Q3 2025
- In the last 3 years, Silence Therapeutics' Other Non-Current Assets had a median value of $3.2 million in 2023 and averaged $3.0 million.
- Over the last 5 years, Silence Therapeutics' Other Non-Current Assets had its largest YoY gain of 3130.42% in 2025, and its largest YoY loss of 8567.68% in 2025.
- Over the past 3 years, Silence Therapeutics' Other Non-Current Assets (Quarter) stood at $3.2 million in 2023, then rose by 12.11% to $3.6 million in 2024, then plummeted by 88.89% to $399000.0 in 2025.
- Its last three reported values are $399000.0 in Q3 2025, $3.9 million for Q2 2025, and $3.6 million during Q1 2025.